Integra Lifesciences Holdings Corp (IART) Form 4 Filed by Michael J. Mcbreen, Mar 06, 2023
SEC Form 4 · No Market Transaction
Tax Withholding
Shares withheld for tax obligations.
Equity Position
30.6K sh
31,362 → 30,639
Equity Change
-2.3%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Michael J. Mcbreen CIK 0001814943 |
EVP
|
Michael J. Mcbreen at Integra Lifesciences Holdings Corp
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Integra Lifesciences Holdings Corp
| 2026-06-03 | Award | — | View |
| 2026-03-12 | Award | — | View |
| 2025-03-13 | Award | — | View |
| 2025-03-11 | - | — | View |
| 2024-12-03 | Sell | -$41,063 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2023-03-02 | F - Tax Payment | 723 D | $55.09 | -$39,830 | 30,639 | Direct |
Related filings at Integra Lifesciences Holdings Corp
Institutional Holders
13F holders · Jun 30, 2026
212
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $192M
- Rubric Capital Management Lp $139M
- Invesco Ltd. $67.3M
5%+ Holders · 13D/G
3 filers
Other insiders at Integra Lifesciences Holdings Corp
GET /v1/forms/4/0001209191-23-016360
API docs
View Original SEC Filing